Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In vivo models of multiple system atrophy

Identifieur interne : 000420 ( France/Analysis ); précédent : 000419; suivant : 000421

In vivo models of multiple system atrophy

Auteurs : Pierre-Olivier Femagut [États-Unis] ; Imad Ghorayeb [France] ; Elsa Diguet [France] ; Francois Tison [France]

Source :

RBID : Pascal:05-0457468

Descripteurs français

English descriptors

Abstract

Multiple system atrophy (MSA) is a sporadic adult-onset neurodegenerative disorder of unknown etiology clinically characterized by a combination of parkinsonian, pyramidal, and cerebellar signs. Levodopa-unresponsive parkinsonism is present in 80% of MSA cases, and this dominant clinical presentation (MSA-P) is associated with a combined degeneration of the substantia nigra pars compacta and the striatum in anatomically related areas. The limited knowledge of the pathophysiology of MSA and the lack of therapeutic strategies prompted the development of lesion models reproducing striatonigral degeneration, the substrate of levodopa-unresponsive parkinsonism in MSA-P. This method was carried out first in rats with two different stereotaxic strategies using either two neurotoxins ("double toxin-double lesion") or a single neuro-toxin ("single toxin-double lesion"). Double-lesioned rat models showed severe motor impairment compared to those with a single nigral or striatal lesion and helped to mimic different stages of the disease. Systemic models were also developed in mice and primates using the nigral toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the striatal toxin 3-nitropropionic (3-NP). In mice, although MPTP reduced the subsequent sensitivity to 3-NP in a sequential lesion, simultaneous nigral and striatal insults were shown to exacerbate striatal damage. MPTP-treated monkeys displayed a significant worsening of parkinsonism and a loss of levodopa-responsiveness after the appearance of hindlimb dystonia and striatal lesion formation induced by subsequent 3-NP intoxication. The different species and intoxication paradigms used will be useful to investigate functional changes in substantia nigra and striatum and to define neuroprotective, neurorestorative, or symptomatic therapeutic strategies.


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:05-0457468

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">In vivo models of multiple system atrophy</title>
<author>
<name sortKey="Femagut, Pierre Olivier" sort="Femagut, Pierre Olivier" uniqKey="Femagut P" first="Pierre-Olivier" last="Femagut">Pierre-Olivier Femagut</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of California Los Angeles</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ghorayeb, Imad" sort="Ghorayeb, Imad" uniqKey="Ghorayeb I" first="Imad" last="Ghorayeb">Imad Ghorayeb</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratoire de Neurophysiologie, Université Victor Segalen Bordeaux2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Diguet, Elsa" sort="Diguet, Elsa" uniqKey="Diguet E" first="Elsa" last="Diguet">Elsa Diguet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratoire de Neurophysiologie, Université Victor Segalen Bordeaux2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="Francois" last="Tison">Francois Tison</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratoire de Neurophysiologie, Université Victor Segalen Bordeaux2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0457468</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0457468 INIST</idno>
<idno type="RBID">Pascal:05-0457468</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001D78</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000F43</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001E21</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Femagut P:in:vivo:models</idno>
<idno type="wicri:Area/Main/Merge">005299</idno>
<idno type="wicri:Area/Main/Curation">003A68</idno>
<idno type="wicri:Area/Main/Exploration">003A68</idno>
<idno type="wicri:Area/France/Extraction">000420</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">In vivo models of multiple system atrophy</title>
<author>
<name sortKey="Femagut, Pierre Olivier" sort="Femagut, Pierre Olivier" uniqKey="Femagut P" first="Pierre-Olivier" last="Femagut">Pierre-Olivier Femagut</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, University of California Los Angeles</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ghorayeb, Imad" sort="Ghorayeb, Imad" uniqKey="Ghorayeb I" first="Imad" last="Ghorayeb">Imad Ghorayeb</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratoire de Neurophysiologie, Université Victor Segalen Bordeaux2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Diguet, Elsa" sort="Diguet, Elsa" uniqKey="Diguet E" first="Elsa" last="Diguet">Elsa Diguet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratoire de Neurophysiologie, Université Victor Segalen Bordeaux2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="Francois" last="Tison">Francois Tison</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Laboratoire de Neurophysiologie, Université Victor Segalen Bordeaux2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Levodopa</term>
<term>Models</term>
<term>Multiple system atrophy</term>
<term>Nervous system diseases</term>
<term>Parkinsonism</term>
<term>Pathophysiology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Système nerveux pathologie</term>
<term>Atrophie multisystématisée</term>
<term>Parkinsonisme</term>
<term>Modèle</term>
<term>Lévodopa</term>
<term>Physiopathologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Multiple system atrophy (MSA) is a sporadic adult-onset neurodegenerative disorder of unknown etiology clinically characterized by a combination of parkinsonian, pyramidal, and cerebellar signs. Levodopa-unresponsive parkinsonism is present in 80% of MSA cases, and this dominant clinical presentation (MSA-P) is associated with a combined degeneration of the substantia nigra pars compacta and the striatum in anatomically related areas. The limited knowledge of the pathophysiology of MSA and the lack of therapeutic strategies prompted the development of lesion models reproducing striatonigral degeneration, the substrate of levodopa-unresponsive parkinsonism in MSA-P. This method was carried out first in rats with two different stereotaxic strategies using either two neurotoxins ("double toxin-double lesion") or a single neuro-toxin ("single toxin-double lesion"). Double-lesioned rat models showed severe motor impairment compared to those with a single nigral or striatal lesion and helped to mimic different stages of the disease. Systemic models were also developed in mice and primates using the nigral toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the striatal toxin 3-nitropropionic (3-NP). In mice, although MPTP reduced the subsequent sensitivity to 3-NP in a sequential lesion, simultaneous nigral and striatal insults were shown to exacerbate striatal damage. MPTP-treated monkeys displayed a significant worsening of parkinsonism and a loss of levodopa-responsiveness after the appearance of hindlimb dystonia and striatal lesion formation induced by subsequent 3-NP intoxication. The different species and intoxication paradigms used will be useful to investigate functional changes in substantia nigra and striatum and to define neuroprotective, neurorestorative, or symptomatic therapeutic strategies.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
<settlement>
<li>Bordeaux</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Femagut, Pierre Olivier" sort="Femagut, Pierre Olivier" uniqKey="Femagut P" first="Pierre-Olivier" last="Femagut">Pierre-Olivier Femagut</name>
</region>
</country>
<country name="France">
<noRegion>
<name sortKey="Ghorayeb, Imad" sort="Ghorayeb, Imad" uniqKey="Ghorayeb I" first="Imad" last="Ghorayeb">Imad Ghorayeb</name>
</noRegion>
<name sortKey="Diguet, Elsa" sort="Diguet, Elsa" uniqKey="Diguet E" first="Elsa" last="Diguet">Elsa Diguet</name>
<name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="Francois" last="Tison">Francois Tison</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000420 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000420 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     Pascal:05-0457468
   |texte=   In vivo models of multiple system atrophy
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024